by ecancer reported Janet Fricker Just under one third of novel therapeutics have been affected by a postmarket safety event by 10 years after Federal Drugs Administration (FDA) approval, finds a US study published in JAMA. Postmarket safety events were...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pO05aT
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
This case report outlines the possibility of accelerated tooth movement with the combination of microosteoperforation and mini-screws. A 14-...
-
by Sofie V. Nielsen, Amelie Stein, Alexander B. Dinitzen, Elena Papaleo, Michael H. Tatham, Esben G. Poulsen, Maher M. Kassem, Lene J. Rasm...
-
The secondary channel (SC) of multisubunit RNA polymerases (RNAPs) allows access to the active site and is a nexus for the regulation of tra...
-
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor British Journal of Canc...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2juls25 via IFTTT
-
Viruses, Vol. 10, Pages 107: Recombinant Goose Circoviruses Circulating in Domesticated and Wild Geese in Poland Viruses doi: 10.3390/v1003...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qoeMDm via IFTTT
-
A critical step in cellular-trafficking pathways is the budding of membranes by protein coats, which recent experiments have demonstrated ca...
-
Abstract Autogenous bone fragments generated during surgery (e.g. implant site preparation) accelerate bone formation by the release of a l...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου